Japan could become one of the first countries in the world to end the HIV epidemic, says the president of Gilead Sciences Japan, Kennet Brysting. The idea for now could seem a little too ambitious, but it is not entirely unrealistic, given that the availability of medicines that can prevent transmission of HIV. Drugs are not the cure, but control over the spread of virus to the point where the disease is no longer a major public health threat.

What Is The Role Of Preventative HIV Medicines?

Gilead's have two key drugs, Truvada and lenacapavir. These two are playing a crucial role in prevention. Truvada is taken as a daily pill, while lenacapavir requires two injections per year. It can make the virus undetectable in infected individuals and prevent transmission to those who are not infected yet. In trials, lenacapavir showed 100% efficacy in preventing HIV infections. This is why it is describe as "almost a vaccine".

In 2024, Japan also approved Truvada for HIV prevention, but the country has yet to approve lenacapavir for the same. Until now, people in Japan had been importing generic versions of Truvada or purchasing it from clinics that source it from overseas.

HIV In Japan

Up until now, Japan reported around 25,000 HIV infections, whereas 669 new cases were reported in 2023. For seven consecutive years, the number of new infections remained under 1,000. The downward trend thus shows that the virus has been controlled, however, getting to zero new infections remains the ultimate goal.

Brysting too acknowledged that simply having effective drug is not enough. What is important is to have a proper implementation, access and healthcare support to make sure that these treatments are widely available and effective.

What Are The Challenges In Implementation?

The biggest challenges is testing rates. There is a need to increase testing rates. At this very moment, around 86% people infective with Japan have been tested, but the goal is to increase it up to 95%, with an ideal goal of 100%. Without widespread testing, many infected people may not even know that they are infected and it could transmit the virus.

Another measure issue is the cost of preventative medication. While Japan's health insurance covers treatments for diseases, it does not cover preventative drugs. Those who purchase Truvada for prevention, pay around $470 per month. Some clinics in Tokyo offer generic alternatives too, which is cheaper, but they are not ideal.

Better Healthcare Support

Brysting expressed concern that individuals importing medications might not be consulting doctors regularly, which is essential for monitoring HIV status and overall health. Truvada users need to be tested for HIV initially and every three months, along with screenings for other infections and kidney function checks. Without proper medical supervision, there is a risk of misuse and inadequate protection.

Gilead is in discussions with Japanese authorities to improve access and insurance coverage for Truvada, and progress is being made. Japan has shown efficiency in approving critical medicines, as seen during the COVID-19 pandemic when Gilead’s remdesivir was approved in just three days.

What Is The Way Ahead?

Gilead at this moment is not only focused on HIV and hepatitis C, but also expanding into oncology with innovative treatments like CAR-T cell therapy, which strengthens a patient's immune system to fight cancer.

However, Japan’s strict approval processes can slow down drug availability. Phase 3 clinical trials often need to be conducted within the country, and Japan tends to approve medicines much later than other regions. For instance, Truvada was approved for prevention in Japan 12 years after the U.S. and nearly 20 years after its approval for treatment. inancial factors also play a role. The Japanese government adjusts drug prices annually, often reducing them, which can make long-term investment challenging for pharmaceutical companies.

The US Centers for Disease Control and Prevention (CDC) has given a warning on having cosmetic surgeries in foreign nations, as it can cause serious infection, even in some cases, death.

CDC, in its report, has shed light on the fact that aesthetic surgeries such as breast augmentation, liposuction, and other elective procedures are performed both within the United States and abroad. This cosmetic enhancement is causing growing concern for public health.

CDC’s journal Emerging Infectious Diseases also published a study regarding the danger and fatality surrounding the beauty enhancement surgeries. This study screened over 2,100 reports of U.S. citizens who travelled in foreign nations between 2014 and 2024.

This CDC research identifies 21 reports involving approximately 145 patients who experienced severe adverse health effects after undergoing beauty enhancement procedures within and outside the US. Notably, four out of these patients even died due to having these surgeries.

The report also mentioned the reasoning behind this alert, as many of these clinics and facilities are causing infections and even death due to their outdated and careless infection-control practices, which include improper environmental cleaning, lack of use of personal protective equipment, a shortfall in hand hygiene, and repeated use of some surgical instruments.

Kiara McNamara, a CDC nurse epidemiologist and lead author of the study, said, “More and more people are getting medical procedures outside the United States, but there are risks.”

The CDC has urged U.S. nationals to research thoroughly before having cosmetic procedures in healthcare facilities abroad.

Also Read: Donald Trump: As The President Boasts Cognitive Test Score - Truth Social Posts Suggest Otherwise

Norovirus Spreading Across the U.S.

The United States is once again witnessing a surge in norovirus infections, a highly contagious gastrointestinal illness that causes severe vomiting and diarrhea.

Media reports noted that hikers along Southern California's Pacific Crest Trail have been hit by a fast-spreading outbreak of what is often referred to as the "winter vomiting disease".

At least two dozen hikers have fallen ill along the trail over the past two weeks, resulting in at least one air rescue. Health officials believe the cases are linked to norovirus, USA Today reported.

Also Read: Norovirus Spreading Across US: What To Know About The Highly Contagious Vomiting Virus

In addition, the latest data from the US Centers for Disease Control and Prevention's National Respiratory and Enteric Virus Surveillance System also showed that norovirus cases have increased over several weeks following a sharp seasonal decline that began in March.

About 11.2 per cent of administered norovirus tests returned positive during the week ending April 28. That figure rose to 12 per cent in the week ending May 2.

Norovirus is commonly associated with the colder months, when respiratory illnesses such as flu and the common cold are widespread.

However, health experts note that late-spring increases in norovirus activity are not unusual, and outbreaks can occur throughout the year due to the virus's highly contagious nature, the report said.

President Donald Trump is boasting about his cognitive test score and claiming he has the highest score possible, but his comments on Truth Social have started a debate that questions the test itself.

President Trump is saying that he had a perfect score of 30 out of 30 in the cognitive test at Walter Reed National Military Medical Center, which, according to him, is a sign of “extreme intelligence.” On the other hand, experts are at odds with him in this regard, as the whole test is for screening cognitive function, not for calculating intelligence.

What Did President Donald Trump Say About His Cognitive Test Results?

The president is saying that he has achieved a full score in a very difficult test. He said, “Unlike other US Presidents, none of whom have ever taken an approved, high difficulty, Cognitive Test, I scored a perfect 30 out of 30, considered ‘extreme intelligence.’”

“In fact, this is my fourth such test, all PERFECT or 120 correct answers out of 120 questions asked! Anyone rarely gets a Perfect Score, especially when achieved four times in a row.” He wrote in his post.

He also demanded that the candidates for president and vice president should also go through this kind of test by saying, “In fact, this is my fourth such test, all PERFECT or 120 correct answers out of 120 questions asked! Anyone rarely gets a Perfect Score, especially when achieved four times in a row.”

Also Read: US CDC Health Alert: Deadly Risks and Infections Linked to Cosmetic Surgeries Abroad

Why Did Experts Question Repeated Testing?

Trump’s claims were immediately questioned by experts like Dr. Jonathan Reiner and Abby Phillip of CNN. They argued that repeated tests may not provide the same value. According to them, as the president had taken the test several times and the questions didn't change that much, it was easy. Other than that, the test is not designed to calculate intellect; it is more of a dementia screening test.

Also Read: Norovirus Spreading Across US: What To Know About The Highly Contagious Vomiting Virus

Questions Raised Over Cardiovascular And Cholesterol Details

According to experts, the physical examination lacks detailed results from tests used to assess cardiovascular health.

Barbabella’s description of Trump’s cardiac health cites results from a coronary CT angiography, an echocardiogram, and an artificial-intelligence-enhanced electrocardiogram analysis.

Jonathan Reiner, Professor of Medicine and Surgery, Interventional Cardiologist, in a post on social media platform X, questioned the need for another coronary artery CT on Trump, as he was last scanned in October.

"We don’t typically scan patients 6 months later unless we are concerned about a finding on the initial scan. What prompted the repeat CT?" he said.

Further, Trump’s cholesterol numbers and medication regimen also attracted attention from physicians who reviewed the memorandum.

According to the report, his HDL (good cholesterol) level was 70 mg/dL, while his LDL (bad cholesterol) level was 53 mg/dL.

The report said Trump takes rosuvastatin and ezetimibe for cholesterol management.

“He’s got like the best cholesterol numbers you’ll see,” said Daniel Torrent, adding that it is unusual for medication alone to achieve such favorable values. “We don’t usually manage people to the point where they’re that good.”

The United States is once again witnessing a surge in norovirus infections, a highly contagious gastrointestinal illness that causes severe vomiting and diarrhea.

Media reports noted that hikers along Southern California's Pacific Crest Trail have been hit by a fast-spreading outbreak of what is often referred to as the "winter vomiting disease".

At least two dozen hikers have fallen ill along the trail over the past two weeks, resulting in at least one air rescue. Health officials believe the cases are linked to norovirus, USA Today reported.

Wastewater Data Shows Rising Activity

According to data from WastewaterSCAN, a Stanford University-led program that tracks disease activity through wastewater testing, norovirus activity was "high" and on an upward trend nationwide in late May.

The surveillance data showed norovirus was detected in 100 per cent of samples collected during May, with concentrations particularly high in the Northeast and Midwest regions of the country.

CDC Reports Increase In Cases

Also read: Western Australia Records 22 Mpox Infections In 2026; Seven Reported Last Week

In addition, the latest data from the US Centers for Disease Control and Prevention's National Respiratory and Enteric Virus Surveillance System also showed that norovirus cases have increased over several weeks following a sharp seasonal decline that began in March.

About 11.2 per cent of administered norovirus tests returned positive during the week ending April 28. That figure rose to 12 per cent in the week ending May 2.

Norovirus is commonly associated with the colder months, when respiratory illnesses such as flu and the common cold are widespread.

However, health experts note that late-spring increases in norovirus activity are not unusual, and outbreaks can occur throughout the year due to the virus's highly contagious nature, the report said.

What Is Norovirus And Its Common Symptoms?

Norovirus causes viral gastroenteritis, sometimes called “stomach flu” or a “stomach bug,” though it isn’t related to influenza. As per Mayo Clinic, it consists of several strains of RNA viruses that inflame the stomach and intestines, causing nausea, vomiting, and diarrhea.

Symptoms usually appear one to two days after exposure and often include:

• Nausea
• Vomiting (non-bloody)
• Watery diarrhea
• Stomach cramps
• Dehydration (rare but possible)
• Fever
• Headache
• Body aches

Most people recover within one to three days, though they can still spread the virus for up to two weeks after feeling better.

Read More: John Barnes, Bobby Davro Diagnosed With Prostate Cancer Even As UK Rules Out Universal Screening

Who Gets Norovirus?

Anyone can get infected. Norovirus is the leading cause of acute gastroenteritis in the US, affecting all ages. Young children, older adults, pregnant people, and individuals with existing health conditions are more vulnerable.

How Does Norovirus Spread?

Norovirus spreads very easily. It survives well in the environment, and only a minuscule amount is enough to infect someone. In fact, just a few particles on the head of a pin can infect over 1,000 people.

Exposure can happen through:

• Eating contaminated water or food, especially leafy greens, fresh fruit, and shellfish like oysters
• Contact with vomit or fecal particles from someone who is infected, either by touching them directly or by touching contaminated surfaces, utensils, or toys.